Posts

Showing posts with the label Generalized Anxiety Disorder (GAD) competitive landscape

Generalized Anxiety Disorder (GAD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Generalized anxiety disorder (GAD) is a mental health condition characterized by persistent feelings of fear, worry, and being overwhelmed. It involves excessive and unrealistic concerns about daily matters, possibly stemming from various factors such as stress, underlying medical conditions like diabetes, co-existing conditions like depression, genetic predisposition (with about a 25% likelihood among first-degree relatives), and environmental influences like childhood trauma or substance abuse. While the exact cause remains unclear, research suggests the involvement of neurotransmitter systems like noradrenaline and serotonin in the body's stress response, with low serotonin activity and heightened noradrenergic activity potentially contributing to its development. Normal anxiety can manifest in children, typically starting with stranger anxiety around seven to nine months of age. Diagnosis of GAD may involve thyroid function tests, blood glucose monitoring, echocardiography, an...

Generalized Anxiety Disorder (GAD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Generalized Anxiety Disorder (GAD) is a mental illness characterized by persistent anxiety, excessive worry, and tension that occurs without reason. GAD can prevent sufferers from executing even the simplest daily tasks in their most extreme form. Patients suffering from GAD are overly concerned about routine life issues, including health, money, career, and relationships. They can't relax, are easily startled, and have trouble concentrating. Although considered one of the most common anxiety disorders, relatively little is understood about the precursors to GAD and other chronic anxiety conditions, including Panic Disorder (PD), Obsessive-Compulsive Disorder (OCD), and Post-Traumatic Stress Disorder (PTSD). Disease development is believed to be multi-causal, influenced by environment and experience, psychological traits, and genetic factors. The prevalence of Generalized Anxiety Disorder (GAD) varies from 3.5% to 17.5% cases among 18 years and older population. Thela...